Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Infante

Showing results (181-190 of 354) with videos related to

Pageof 36
Sort By:
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 22, 1999
Evaluation of tumor marker S-100 in cerebrospinal fluid from subjects with nonischemic brain pathologiesJ R Infante, M Torres-Avisbal, A Martinez, et al.
Revista Espanola De Fisiologia|December 1, 1992
[Diurnal variations in circulating leukocytes and subsets: relation to plasma cortisol and ACTH]F Rodríguez, R E Méndez, J A Castilla, et al.
Revista Espanola De Medicina Nuclear E Imagen Molecular|July 2, 2020
<sup>18</sup>F-FDG PET/CT quantitative parameters as prognostic factor in localized and inoperable lung cancerJ R Infante, J Cabrera, J I Rayo, et al.
Revista Espanola De Medicina Nuclear E Imagen Molecular|August 28, 2021
Baseline <sup>18</sup>F-FDG PET/CT quantitative parameters as prognostic factors in esophageal squamous cell cancerA Martínez, J R Infante, J Quirós, et al.
Eclinicalmedicine|June 24, 2022
Phase I study of PT-112, a novel pyrophosphate-platinum immunogenic cell death inducer, in advanced solid tumoursDaniel D Karp, D Ross Camidge, Jeffery R Infante, et al.
Revista Espanola De Medicina Nuclear E Imagen Molecular|June 5, 2021
Baseline <sup>18</sup>F-FDG PET/CT quantitative parameters as prognostic factors in esophageal squamous cell cancerA Martínez, J R Infante, J Quirós, et al.
Cancer Chemotherapy and Pharmacology|August 2, 2012
A phase I trial of oral administration of panobinostat in combination with paclitaxel and carboplatin in patients with solid tumorsSuzanne F Jones, Jeffrey R Infante, Dana S Thompson, et al.
Investigational New Drugs|May 2, 2012
Unexpected renal toxicity associated with SGX523, a small molecule inhibitor of METJeffrey R Infante, Terence Rugg, Michael Gordon, et al.
Clinical Pharmacology in Drug Development|April 29, 2016
Pharmacokinetics of Irinotecan With and Without Panitumumab Coadministration in Patients With Metastatic Colorectal CancerBing-Bing Yang, Chi-Yuan Wu, Eric Chen, et al.
British Journal of Cancer|January 16, 2014
Intermittent dosing of axitinib combined with chemotherapy is supported by (18)FLT-PET in gastrointestinal tumoursC K Hoh, H A Burris, J C Bendell, et al.
Pageof 36

Showing results (181-190 of 354) with videos related to

Sort By:
Pageof 36
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 22, 1999
Evaluation of tumor marker S-100 in cerebrospinal fluid from subjects with nonischemic brain pathologiesJ R Infante, M Torres-Avisbal, A Martinez, et al.
Revista Espanola De Fisiologia|December 1, 1992
[Diurnal variations in circulating leukocytes and subsets: relation to plasma cortisol and ACTH]F Rodríguez, R E Méndez, J A Castilla, et al.
Revista Espanola De Medicina Nuclear E Imagen Molecular|July 2, 2020
<sup>18</sup>F-FDG PET/CT quantitative parameters as prognostic factor in localized and inoperable lung cancerJ R Infante, J Cabrera, J I Rayo, et al.
Revista Espanola De Medicina Nuclear E Imagen Molecular|August 28, 2021
Baseline <sup>18</sup>F-FDG PET/CT quantitative parameters as prognostic factors in esophageal squamous cell cancerA Martínez, J R Infante, J Quirós, et al.
Eclinicalmedicine|June 24, 2022
Phase I study of PT-112, a novel pyrophosphate-platinum immunogenic cell death inducer, in advanced solid tumoursDaniel D Karp, D Ross Camidge, Jeffery R Infante, et al.
Revista Espanola De Medicina Nuclear E Imagen Molecular|June 5, 2021
Baseline <sup>18</sup>F-FDG PET/CT quantitative parameters as prognostic factors in esophageal squamous cell cancerA Martínez, J R Infante, J Quirós, et al.
Cancer Chemotherapy and Pharmacology|August 2, 2012
A phase I trial of oral administration of panobinostat in combination with paclitaxel and carboplatin in patients with solid tumorsSuzanne F Jones, Jeffrey R Infante, Dana S Thompson, et al.
Investigational New Drugs|May 2, 2012
Unexpected renal toxicity associated with SGX523, a small molecule inhibitor of METJeffrey R Infante, Terence Rugg, Michael Gordon, et al.
Clinical Pharmacology in Drug Development|April 29, 2016
Pharmacokinetics of Irinotecan With and Without Panitumumab Coadministration in Patients With Metastatic Colorectal CancerBing-Bing Yang, Chi-Yuan Wu, Eric Chen, et al.
British Journal of Cancer|January 16, 2014
Intermittent dosing of axitinib combined with chemotherapy is supported by (18)FLT-PET in gastrointestinal tumoursC K Hoh, H A Burris, J C Bendell, et al.
Pageof 36